The Trendlines Group Update April 2014


Creating & Developing Companies To Improve the Human Condition

… Trendlines Labs and Sheba Medical Center agreement … Patent for NovoSpeech … Endobetix, NeuroQuest, and Sol Chip in media … Investment Event and Agrivest videos …


Steve Rhodes and Todd Dollinger of The Trendlines Group

News from Trendlines Medical

  • T2D treatment from Endobetix supported by new study in Nature.
  • NeuroQuest advisor: “Stronger immune system could cure Alzheimer’s.”
  • Trendlines Medical CEO Eran Feldhay featured in G magazine.
  • The spotlight is on: SiL Vascular‘s novel treatment for peripheral vascular disease.

News from Trendlines Agtech

  • Sol Chip‘s “solar battery that doesn’t need sun,” an Israel21c feature.
  • Nitza Kardish, Trendlines Agtech CEO, writes, “The world is hungry, and Israel can feed it” for an article in The Marker. Nitza was also the subject of an interview in IsraelAgri.
  • Missed our 2nd Agrivest conference? See all the action.

Leave a Reply

  • Welcome to Trendlines

    We invest in, incubate, and support early-stage, high-promise medical and agricultural technology companies in Israel, a global leader in start-up ingenuity. Read More >

  • Categories

  • Subscribe to Our Newsletter

  • Stay in Touch

    icon-facebook Like us on Facebook

    icon-Twitter Follow us on Twitter

    icon-Linkedin Connect with us on Linkedin

    YouTube-color See us on YouTube

    flipboard  Read us on Flipboard

    google+_icon Join us on Google+

Font Resize